Modulation of angiogenic factors by ursolic acid

Biochemical and Biophysical Research Communications

Volumn 371, Issue 3, 2008, Pages 556-560

  Kiran, M S ^a   Viji, R I ^a   Sameer Kumar, V B ^a   Sudhakaran, P R ^a  

^a UNIVERSITY OF KERALA   (India)

Author keywords

Angiogenesis; COXs; FGF 2; FGFR 1; MAPK; PI3K Akt; Prostaglandins; Ursolic acid; VEGF; VEGFR 2

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROTEIN KINASE B; URSOLIC ACID; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD31; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; E-SELECTIN; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTORS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRITERPENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43549119962     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.108     Document Type: Article

References (29)

1. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
2. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell 86 (1996) 353-364
3. Folkman J., and Shing Y. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
4. Dulak J. Nutraceuticals as anti-angiogenic agents: hopes and reality. J. Physiol. Pharmacol. 56 (2005) 51-69
5. Huang M.T., Ho C.T., Wang Z.Y., Ferraro T., Lou Y.R., Stauber K., Ma W., Georgiadis C., Laskin J.D., and Conney A.H. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 54 (1994) 701-708
6. Subbaramaiah K., Michaluart P., Sporn M.B., and Dannenberg A.J. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res. 60 (2000) 2399-2404
7. Liu J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 49 (1995) 57-68
8. Cardenas C., Quesada A.R., and Medina M.A. Effects of ursolic acid on different steps of the angiogenic process. Biochem. Biophys. Res. Commun. 320 (2004) 402-408
9. Sohn K.H., Lee H.Y., Chung H.Y., Young H.S., Yi S.Y., and Kim K.W. Anti-angiogenic activity of triterpene acids. Cancer Lett. 94 (1995) 213-218
10. Lee H.Y., Chung H.Y., H Kim K., Lee J.J., and Kim K.W. Differentiation induction of the F9 teratocarcinoma cells by triterpene acids. J. Cancer Res. Clin. Oncol. 120 (1994) 513-518
11. Kiran M.S., Kumar V.B., Viji R.I., Sherin G.T., Rajasekharan K.N., and Sudhakaran P.R. Opposing effects of curcuminoids on serum stimulated and unstimulated angiogenic response. J. Cell. Physiol. 215 (2008) 251-264
12. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52 (1973) 2745-2756
13. Kumar V.B., Viji R.I., Kiran M.S., and Sudhakaran P.R. Modulation of expression of LDH isoenzymes in endothelial cells by laminin: implications for angiogenesis. J. Cell. Biochem. 103 (2008) 1808-1825
14. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354
15. Holtmann H., Shemer-Avni Y., Wessel K., Sarov I., and Wallach D. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis. Infect. Immun. 58 (1990) 3168-3172
16. Kiran M.S., Kumar V.B., Viji R.I., and Sudhakaran P.R. Temporal relationship between MMP production and angiogenic process in HUVECs. Cell Biol. Int. 30 (2006) 704-713
17. Kraling B.M., Razon M.J., Boon L.M., Zurakowski D., Seachord C., Darveau R.P., Mulliken J.B., Corless C.L., and Bischoff J. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am. J. Pathol. 148 (1996) 1181-1191
18. Yang S., Graham J., Kahn J.W., Schwartz E.A., and Gerritsen M.E. Functional roles of PECAM-1 (CD-31 and VE-cadherin (CD-144) in tube assembly and lumen formation in three dimensional collagen gels. Am. J. Pathol. 155 (1999) 887-895
19. Pepper M.S., and Mandriota S.J. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells. Exp. Cell Res. 24 (1998) 414-425
20. Gualandris A., Rusnati M., Belleri M., Nelli E.E., Bastaki M., Molinari-Tosatti M.P., Bonardi F., Parolini S., Albini A., Morbidelli L., Ziche M., Corallini A., Possati L., Vacca A., Ribatti D., and Presta M. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ. 7 (1996) 147-160
21. Sola F., Gualandris A., Belleri M., Giuliani R., Coltrini D., Bastaki M., Tosatti M.P., Bonardi F., Vecchi A., Fioretti F., Ciomei M., Grandi M., Mantovani A., and Presta M. Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice. Angiogenesis 1 (1997) 102-116
22. Tille J.C., Wood J., Mandriota S.J., Schnell C., Ferrari S., Mestan J., Zhu Z., Witte L., and Pepper M.S. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. J. Pharmacol. Exp. Ther. 299 (2001) 1073-1085
23. Mandriota S.J., and Pepper M.S. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J. Cell Sci. 110 (1997) 2293-2302
24. Shishodia S., Majumdar S., Banerjee S., and Aggarwal B.B. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63 (2003) 4375-4383
25. Pai R., Szabo I.L., Soreghan B.A., Atay S., Kawanaka H., and Tarnawski A.S. PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem. Biophys. Res. Commun. 286 (2001) 923-928
26. Powell W.S. 15-Deoxy-delta12,14-PGJ2: endogenous PPAR gamma ligand or minor eicosanoid degradation product?. J. Clin. Invest. 112 (2003) 828-830
27. Munoz-Chapulia R., Quesada A.R., and Medina A.M. Angiogenesis and signal transduction in endothelial cells. Cell. Mol. Life Sci. 61 (2004) 2224-2243
28. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90 (2002) 1243-1250
29. Bogatcheva N.V., Dudek S.M., Garcia J.G., and Verin A.D. Mitogen-activated protein kinases in endothelial pathophysiology. J. Invest. Med. 51 (2003) 341-352